In the present study, EECM exerted anti-obesity effects in vitro and in vivo by suppressing the expression of PPARγ, C/EBPα, SREBP-1, and FAS and p-ACC expression via the AMPK pathway. This evidence concerns the gene SREBF1 and obesity disorder.